Skip to main content
TipRanks
Go Ultimate75% OFF
Specific Biologics logo

Specific Biologics: Valuation, Funding & Investors

A biotechnology company developing gene-editing therapies for amyotrophic lateral sclerosis and other repeat expansion disorders. Its platform is designed to precisely remove disease-causing DNA repeat expansions and advance targeted therapeutic candidates into clinical development.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$35M
Total Funding Rounds
1
Latest Funding Amount
$35M
Latest Funding Round
Series A

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Nov 02, 2026Series A$35.00M―

Investors

Investor NameFunding Round
Hatteras Venture PartnersSeries A
Lumira VenturesSeries A
adMare BioInnovationsSeries A

Similar Companies

A snapshot of private companies similar to Specific Biologics, helping you discover and navigate related company profiles.

Related News and Analysis